pindolol has been researched along with atenolol in 220 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 131 (59.55) | 18.7374 |
| 1990's | 46 (20.91) | 18.2507 |
| 2000's | 23 (10.45) | 29.6817 |
| 2010's | 18 (8.18) | 24.3611 |
| 2020's | 2 (0.91) | 2.80 |
| Authors | Studies |
|---|---|
| Baldwin, JJ; Christy, ME; Denny, GH; Freedman, MB; Gross, DM; Habecker, CN; Lyle, PA; Ponticello, GS; Sweet, CS; Varga, SL | 1 |
| Alexander, J; Cargill, R; Michelson, SR; Schwam, H | 1 |
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Artursson, P; Beigi, F; Lundahl, P; Luthman, K; Palm, K; Strandlund, G; Ungell, AL | 1 |
| Ghuloum, AM; Jain, AN; Sage, CR | 1 |
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Ertl, P; Rohde, B; Selzer, P | 1 |
| Artursson, P; Luthman, K; Norinder, U; Stenberg, P | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
| Caron, G; Ermondi, G | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bode, ML; Gravestock, D; Hoppe, HC; Khan, T; Moleele, SS; Nkabinde, LA; Pelly, SC; Steenkamp, PA; van der Westhuyzen, CW | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ammazzalorso, A; Amoia, P; Amoroso, R; Cilurzo, F; De Filippis, B; Fantacuzzi, M; Giampietro, L; Linciano, P; Maccallini, C; Petit, C | 1 |
| Bilski, A; Dawes, PM; Wale, J | 1 |
| Gooren, L; Harms, HH; Hesse, C; Spoelstra, AJ; Verschoor, L | 1 |
| Dickerson, DD; Fulmor, IE; Goldberg, ME; Lee, RJ | 1 |
| Wilcox, RG | 1 |
| Day, MD; Roach, AG | 1 |
| Bühler, FR; Burkart, F; Marbet, G; Patel, U | 1 |
| Kiechel, JR; Meier, J | 1 |
| Hugues, FC; Julien, D; Marche, J; Munera, Y | 1 |
| Berdeaux, A; Giudicelli, JF | 1 |
| Clémenty, J; Dallocchio, M; Dany, F | 1 |
| Dietz, R; Lüth, JB; Mann, JF; Rascher, W; Schömig, A | 1 |
| Bliddal, J; Hartling, O; Lysbo Svendsen, T; McNair, A; Trap-Jensen, J | 1 |
| Bellucci, R; Bonomi, L; Massa, F; Noya, E; Perfetti, S | 1 |
| Brown, B; Buckley, M; Darragh, A; Fitzgerald, D; Foley, JE; O'Kelly, D; Tormey, W; Vukovich, RA; Willard, DA | 1 |
| Hartling, O; Svendsen, TL; Trap-Jensen, J | 1 |
| Louis, WJ; McNeil, JJ | 1 |
| Henningsen, NC; Mattiasson, I | 1 |
| Hellström, PE; Salonen, T | 1 |
| Crino, PB; Jensen, EL; Vogt, BA | 1 |
| Dahlöf, B; Ekbom, T; Hansson, L; Lindholm, LH; Scherstén, B; Wester, PO | 1 |
| Cristal, N; Neumann, L; Paran, E | 1 |
| Cooper, RC; Ekwuru, M; Fletcher, S; Gilbody, J; Husseyin, TS; Ishaque, M; Jagathesan, R; Reddy, G; Smith, SE; Thomas, SH | 1 |
| Ingemarsson, I; Marsál, K; Montan, S; Sjöberg, NO | 1 |
| Cherchi, A; Sau, F; Seguro, C | 1 |
| Holzer, BC; Kostis, JB; Rosen, RC; Seltzer, LG; Taska, LS | 1 |
| Blankestijn, PJ; Boomsma, F; Man in 't Veld, AJ; Schalekamp, MA; van den Meiracker, AH | 1 |
| Lithell, HO | 1 |
| Cobo, C; De Crée, J; Geukens, H; Verhaegen, H | 1 |
| Balasubramaniam, S; Chang, S; Hickie, JB; Simons, LA | 1 |
| Fitscha, P; Meisner, W; Tiso, B | 2 |
| Davidson, JM; Maurice, J; Richardson, R; Smith, ER; Walter, T | 1 |
| Kostis, JB | 1 |
| Enquist, M; Hermansson, J | 1 |
| Brodde, OE; Deighton, NM; Khamssi, M; Motomura, S; Zerkowski, HR | 1 |
| Betteridge, DJ; Graham, B; Prichard, BN; Smith, C; Tomlinson, B; Walden, RJ | 1 |
| Graham, B; Liu, JB; Prichard, BN; Tomlinson, B; Walden, RJ | 1 |
| Koskinen, P; Nieminen, MS; Pellinen, TJ; Rapola, JM; Toivonen, L | 1 |
| Abrahamsen, AM; Digranes, O; Gisholt, K | 1 |
| Nieminen, MS; Pellinen, TJ; Rapola, JM; Toivonen, L | 1 |
| Gautschi, K; Neftel, KA | 1 |
| Dorow, P; Schiess, W | 2 |
| Abetel, G; Genoud, G; Karly, M | 1 |
| Beil, ME; Cabot, CF; Coram, WM; Olson, RW; Weiss, GB | 1 |
| De Cree, J; Janssen, PA; Janssens, W; Reneman, RS; Van de Water, A; Van Neuten, J; Verhaegen, H; Xhonneux, R | 1 |
| Earley, KJ; Tenner, TE; Yen, YC; Young, JA | 1 |
| Hertzeanu, H; Kellermann, JJ; Loidl, AF; Shemesh, J | 1 |
| Christy, JP; Feldman, RD; Harrison, DG; Paul, ST | 1 |
| Bregman, L; Drexler, I; Hochberg, Y; Laszt, A; Mishal, J; Oren, S; Villa, Y; Viskoper, RJ | 1 |
| Forfang, K; Simonsen, S | 1 |
| Antalóczy, Z; Kekes, E | 1 |
| Anderton, JL; Notghi, A; Oliver, MF; Riemersma, RA | 1 |
| Ruskoaho, H | 1 |
| McGourty, JC; Silas, JH; Solomon, SA | 1 |
| Dayer, P; Leemann, T; Marmy, A; Rosenthaler, J | 1 |
| Carrageta, MO; Raftery, EB | 1 |
| Carlsen, JE; McNair, A; Svendsen, TL; Trap-Jensen, J | 1 |
| Baumgart, P; Fehske, KJ; Häcker, W; Karoff, C; Losse, H; Vetter, H; Zidek, W | 1 |
| Floras, JS; Hassan, MO; Jones, JV; Sleight, P | 3 |
| Kawecka-Jaszcz, K; Skoczeń, M | 1 |
| Alford, C; Betts, TA | 1 |
| Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 1 |
| Brownlee, WC; Durrington, PN; Large, DM | 1 |
| de Boo, T; Lemmens, WA; Lenders, JW; Salemans, J; Thien, T; van't Laar, A | 1 |
| Fagher, B; Liedholm, H; Monti, M; Moritz, U | 1 |
| Fishbein, L; Jackson, CD | 1 |
| Barberis, S; Galietti, F; Giorgis, GE; Massaglia, GM; Miravalle, C; Onoscuri, E | 1 |
| Dahlöf, B; Hansson, L; Lindholm, L; Råstam, L; Scherstén, B; Wester, PO | 1 |
| Burris, JF; Goldstein, J; Plachetka, JR; Sirgo, MA; Sutton, JM; Zager, PG | 1 |
| Edwards, E; Whitaker-Azmitia, PM | 1 |
| Clarke, BF; Ewing, DJ; Harry, JD; Neilson, JM; Reid, W; Smith, HJ | 1 |
| Desager, JP; Harvengt, C; Heller, F; Hulhoven, R | 1 |
| McGourty, JC; Silas, JH | 1 |
| Adebayo, GI; Mabadeje, AF; Oyenuga, AB | 1 |
| Breckenridge, AM; Grimmer, SF; Orme, ML; Roberts, DH; Tsao, Y; Winstanley, PA | 1 |
| Colnago, R; Fiorella, G; Guffanti, EE; Mazzola, C; Meregalli, M; Nazzari, M; Turri, D | 1 |
| Breckenridge, A; McLoughlin, GA; Roberts, DH; Tsao, Y | 1 |
| Harvengt, C; Heller, FR; Martiat, P; Van Nieuwenhuyze, Y | 1 |
| Srivastava, KC | 1 |
| Jekelis, AW; Kostis, JB; Rosen, RC | 1 |
| Nieminen, MS; Pellinen, TJ; Rapola, J; Toivonen, L | 1 |
| Blankestijn, PJ; Boomsma, F; Man in't Veld, AJ; Schalekamp, MA; van den Meiracker, AH | 1 |
| Beld, AJ; Hermanussen, MW; Lammers, JW; Rodrigues de Miranda, JF; van Ginneken, CA; van Koppen, CJ; Verrijp, KN | 1 |
| Boomsma, F; Man in 't Veld, AJ; Schalekamp, MA; van den Meiracker, AH; van Eck, HJ | 1 |
| Amiel, A; Boutaud, P; Ciber, MA; Demange, J; Guillard, O; Herpin, D; Piriou, A | 1 |
| James, MA; Jordan, SC; Papouchado, M | 1 |
| Lehtonen, A | 1 |
| Burke, M; McCaffrey, PM; Riddell, JG; Shanks, RG | 1 |
| Demeter, RJ; Judy, WV; Nyhuis, AW; Toth, PD; Woods, JR | 1 |
| Maltbaek, N; Rehling, M; Svendsen, TL; Tangø, M; Trap-Jensen, J | 2 |
| Friis, T; Jespersen, CM; Jørgensen, PH; Krogsgaard, AR | 1 |
| Boström, PA; Janzon, L; Ohlsson, O; Westergren, A | 1 |
| Capra, A; Fogari, R; Pasotti, C; Rebagliati, M; Zoppi, A | 1 |
| Calder, AA; Forbes, CD; Greer, IA; Walker, JJ | 1 |
| Foerster, EC; Greminger, P; Siegenthaler, W; Vetter, H; Vetter, W | 1 |
| Vidt, DG | 1 |
| Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C | 1 |
| Frishman, WH; Koch-Weser, J | 1 |
| Hedges, A; Kilfeather, S; Lima, DR; Turner, P | 1 |
| Lindell, SE; Ohlsson, O | 1 |
| Carroll, JD; Jefferson, D; Taylor, EA; Turner, P | 1 |
| Gabe, IT; Kimber, H; Mills, CJ; Sweeting, TJ; Thomas, M | 1 |
| Kudo, Y; Sokabe, H; Zehr, JE | 1 |
| Moulopoulos, S; Raptis, S; Rosenthal, J; Welzel, D | 1 |
| O'Donnell, SR; Wanstall, JC | 1 |
| Mattioli, G; Menozzi, A; Ricci, S; Teglio, V | 1 |
| Al-Khader, A; Hernandez, J; Prichard, BN; Walden, RJ; Yu, Y | 1 |
| Erikssen, J; Mundal, R; Nitter-Hauge, S; Opstad, P; Thaulow, E | 1 |
| Behrenbeck, DW; Braun, V; Gil-Sanchez, D; Hilger, HH; Hombach, V; Höpp, HW; Tauchert, M | 1 |
| Lohmöller, G; Stocker, K | 1 |
| Alpers, JH; Crockett, AJ; Latimer, KM; McIntyre, EL; Ruffin, RE; Ward, HE | 1 |
| Catherine, P; Dubois, D; Klepper, A; Petitcolas, J; Temperville, B | 1 |
| Raptis, S | 1 |
| Ahmad, D; Carruthers, SG; Hamilton, JT; Twum-Barima, Y | 1 |
| Gerstenbrand, F; Klingler, D; Poewe, W | 1 |
| Bellomo, G; Corradi, L; Fogari, R; Marchesi, E; Parini, A | 1 |
| Fellenius, E | 1 |
| Himori, N; Ishimori, T; Iwamura, M; Izumi, A; Makino, M; Yasuda, K | 1 |
| Lund-Johansen, P | 1 |
| Himanen, P; Huupponen, R; Lehtonen, A | 1 |
| Escriba Polo, A; Fernandez Pinilla, C; Fernandez-Cruz, A; Luque Otero, M; Martell Claros, N; Rodriguez Vazquez, M | 1 |
| Jackson, EA; Sullman, SA | 1 |
| Ingemarsson, I; Liedholm, H; Melander, A; Montan, S; Westgren, M | 1 |
| Kirch, W; Mutschler, E; Spahn, H | 2 |
| Cherenshchikova, EA; Filippov, AK; Iuzhakov, SD; Mashkovskiĭ, MD; Porotikov, VI | 1 |
| Chung, DC; Laschuk, MJ | 1 |
| Beaulieu, G; Grimes, D; Muirhead, C; Oshiro, G | 1 |
| Friedewald, WT; Frishman, WH; Furberg, CD | 1 |
| Peele, ME; Shulkin, BL; Utiger, RD | 1 |
| McGoon, MD; Vlietstra, RE | 1 |
| Cosgrove, NM; Kostis, JB; Krieger, SD; Lacy, CR | 1 |
| Fox, KM; Mockus, L; Quyyumi, AA; Wright, C | 1 |
| Abed, J; Donaldson, R; Nashat, F; Taggart, P | 1 |
| Gugler, R; Schiess, W; Welzel, D | 1 |
| Abetel, G; Bousquet, JC; Genoud, A; Karly, M; Mérier, G | 1 |
| Engel, G | 1 |
| Ihlen, H; Simonsen, S; Welzel, D | 1 |
| Clapp, RJ; Frewin, DB; Leonello, PP; Penhall, RK | 1 |
| Danielson, M; Lundbäck, M | 1 |
| England, JD | 1 |
| Baumgart, P; Boerlin, HJ; Greminger, P; Havelka, J; Lüscher, T; Siegenthaler, W; Vetter, H; Vetter, W; Walger, P | 1 |
| Taylor, EA; Turner, P | 1 |
| Ambrosioni, E; Costa, FV; Magnani, B; Marata, AM; Montebugnoli, L; Rosati, G | 1 |
| Channer, KS; James, MA; MacConnell, T; Rees, JR | 1 |
| Klug, S; Merker, HJ; Neubert, D; Schwabe, R; Thiel, R | 1 |
| Kastelova, A; Stoytchev, T | 1 |
| Jiang, MH; Peng, HL; Yang, ZC | 1 |
| Egginger, G; Klein, W; Lindner, W; Stoschitzky, K; Zernig, G | 1 |
| Jouppila, P; Räsänen, J | 1 |
| Buckley, NA; Dawson, AH; Epid, D; Reith, DM; Sayer, GP; Whyte, IM | 1 |
| Kaila, T; Kantola, I; Ruskoaho, H; Scheinin, M; Tarssanen, L; Viinamäki, O | 1 |
| Asano, M; Azuma, H; Hashimoto, S; Ito, Y; Kato, H; Morikawa, K; Ohashi, T | 1 |
| Clark, JT; Davidson, JM; Hoffman, BB; Kacker, SR; Raskin, A; Smith, ER; Yun, PT | 1 |
| Hattori, K; Hosohata, Y; Maruyama, K; Nagatomo, T; Ohnuki, T; Sasaki, K; Suzuki, J; Watanabe, K | 1 |
| Alexander, SP; Hernández, F; Kendall, DA; Neil, KE | 1 |
| Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
| Fernandes, AC; Filipe, PM; Manso, CF; Silva, JM | 1 |
| Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
| Hattori, K; Hosohata, Y; Kaneko, H; Nagatomo, T; Ohnuki, T; Okuyama, M; Shen, Y; Suzuki, J | 1 |
| Doggrell, SA; Henderson, CJ | 1 |
| Riddell, JG; Silke, B | 1 |
| Chen, X; Floras, JS; Hassan, MO; Jones, JV; Sleight, P | 1 |
| Hakko, H; Räsänen, P; Tiihonen, J | 1 |
| Cherian, A; Mustafa, SM; Oriowo, MA; Yousif, M | 1 |
| Black, M; Cayenne, S; Cohen, TJ; Doolittle, S; Ibrahim, B; Quan, W | 1 |
| Hanratty, CG; Riddell, JG; Silke, B; Veres, SM | 1 |
| D'Agostino, B; Falciani, M; Fici, F; Filippelli, A; Gallelli, L; Mangrella, M; Rossi, F | 1 |
| Alegria, JR; Gersh, BJ; Hammill, SC; Hodge, DO; Scott, CG; Shen, WK | 1 |
| Aturki, Z; Cristalli, M; D'Orazio, G; Fanali, S; Quaglia, MG | 1 |
| Da Silva, A; Mendonca, D; Paravastu, SC | 1 |
| Hu, X; Hu, Y; Li, G; Pan, J | 1 |
| Sal'nikov, EV | 1 |
| Froehlich, D; Graf, B; Gruber, M; Lunz, D; Trabold, B | 1 |
| Del Giaccio, A; Eblen-Zajjur, A | 1 |
| Pisklak, DM; Wawer, I; Zielińska-Pisklak, MA | 1 |
| Morante-Zarcero, S; Sierra, I | 1 |
| Da Silva, A; Mendonca, DA; Paravastu, SC | 1 |
| Demir, Y | 1 |
| Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V | 1 |
| Breadmore, MC; Gooley, AA; Guijt, RM; Mikhail, IE; Tehranirokh, M | 1 |
18 review(s) available for pindolol and atenolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Meta-Analysis as Topic; Metoprolol; Pindolol; Propranolol; Prospective Studies | 1991 |
Hypertension and beta-blockers. Are they all the same?
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Labetalol; Metoprolol; Pindolol; Receptors, Adrenergic, alpha; Sotalol | 1985 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Oxprenolol; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
[Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
Topics: Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pindolol; Random Allocation | 1988 |
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Metoprolol; Migraine Disorders; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1981 |
[Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Hemodynamics; Humans; Hypertension; Male; Metoprolol; Nadolol; Pindolol; Propanolamines | 1982 |
Muscle fatigue and beta-blockers--a review.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Dose-Response Relationship, Drug; Energy Metabolism; Fatigue; Fatty Acids, Nonesterified; Hemodynamics; Humans; Lactates; Metoprolol; Muscles; Perception; Physical Exertion; Pindolol; Propranolol; Rats; Tissue Distribution | 1983 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; Metoprolol; Migraine Disorders; Myocardial Infarction; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
The new beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Labetalol; Metoprolol; Nadolol; Oxprenolol; Pindolol; Propanolamines; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Beta blockers for peripheral arterial disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Intermittent Claudication; Metoprolol; Peripheral Vascular Diseases; Pindolol; Propranolol; Randomized Controlled Trials as Topic | 2008 |
Beta blockers for peripheral arterial disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Intermittent Claudication; Metoprolol; Peripheral Vascular Diseases; Pindolol; Propranolol; Randomized Controlled Trials as Topic; Regional Blood Flow; Walking | 2013 |
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease; Female; Fetal Growth Retardation; Furosemide; Gestational Age; Humans; Hypertension; Incidence; Infant, Small for Gestational Age; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Perinatal Death; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Severity of Illness Index | 2020 |
76 trial(s) available for pindolol and atenolol
| Article | Year |
|---|---|
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
[Study of the respiratory tolerance of adrenolytic beta-blockers in the asthmatic].
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Bronchial Spasm; Female; Forced Expiratory Volume; Humans; Male; Pindolol; Practolol; Propranolol; Respiration; Vital Capacity | 1978 |
Acute hemodynamic effects of five beta-adrenoceptor blocking agents in man: the significance of selectivity and intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Male; Middle Aged; Pindolol; Practolol; Propranolol; Sympathomimetics | 1979 |
Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Drug Evaluation; Heart Rate; Humans; Kinetics; Male; Middle Aged; Oxprenolol; Physical Exertion; Pindolol; Propanolamines; Propranolol; Time Factors; Timolol | 1979 |
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Metoprolol; Middle Aged; Pindolol; Time Factors | 1979 |
Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system.
Topics: Adult; Aged; Alprenolol; Atenolol; Central Nervous System; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines; Propranolol; Time Factors | 1979 |
[Therapeutic differences between atenolol and pindolol in asthmatic patients].
Topics: Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Hemodynamics; Humans; Hypertension; Pindolol; Placebos; Propanolamines; Respiration; Respiratory Function Tests | 1979 |
Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study.
Topics: Aged; Aged, 80 and over; Amiloride; Atenolol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Pindolol; Prospective Studies; Treatment Outcome | 1992 |
Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics.
Topics: Atenolol; Blood Pressure; Double-Blind Method; Female; Fetus; Heart Rate; Hemodynamics; Humans; Hypertension; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular | 1992 |
Beta blocker effects on heart rate during sleep: a placebo-controlled polysomnographic study with normotensive males.
Topics: Adrenergic beta-Antagonists; Atenolol; Cerebral Cortex; Double-Blind Method; Electrocardiography; Electroencephalography; Exercise Test; Heart Rate; Humans; Male; Metoprolol; Monitoring, Physiologic; Pindolol; Propranolol; Sleep Stages | 1991 |
Epinephrine-induced enhancement of sympathetic activity in humans: inhibition by nonselective as well as beta 1-selective beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cold Temperature; Epinephrine; Hemodynamics; Humans; Middle Aged; Norepinephrine; Physical Exertion; Pindolol; Receptors, Adrenergic, beta; Stress, Psychological | 1990 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Meta-Analysis as Topic; Metoprolol; Pindolol; Propranolol; Prospective Studies | 1991 |
Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Benzopyrans; Blood Pressure; Ethanolamines; Heart Rate; Hemodynamics; Humans; Middle Aged; Nebivolol; Pindolol; Propranolol; Stroke Volume; Systole | 1990 |
Comparison of bopindolol and atenolol in chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Exercise Test; Female; Humans; Male; Middle Aged; Nitroglycerin; Pindolol; Random Allocation; Time Factors | 1990 |
Beta-blocker duration of action and implications for therapy.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Circadian Rhythm; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Nadolol; Pindolol | 1990 |
Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Glucose; Catecholamines; Female; Hormones; Humans; Hydrocortisone; Insulin; Male; Pindolol; Potassium; Prolactin; Reference Values; Substance Withdrawal Syndrome | 1990 |
Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Exercise Test; Female; Heart Rate; Hormones; Humans; Isoproterenol; Male; Pindolol; Reference Values; Substance Withdrawal Syndrome | 1990 |
Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.
Topics: Administration, Oral; Adult; Atenolol; Echocardiography; Exercise; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Pindolol; Systole | 1990 |
Comparison of the side-effects of pindolol and atenolol in the treatment of hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Bradycardia; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Pindolol | 1990 |
Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study.
Topics: Atenolol; Blood Pressure; Cardiac Output; Coronary Disease; Double-Blind Method; Echocardiography; Heart Rate; Hemodynamics; Humans; Pindolol | 1990 |
Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pindolol | 1986 |
Influence of atenolol and bopindolol on circadian heart rate.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Circadian Rhythm; Female; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Pindolol; Rest | 1986 |
Evaluation of the antihypertensive effect of a beta-blocker with the aid of daily blood pressure profiles.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Circadian Rhythm; Female; Humans; Male; Middle Aged; Pindolol | 1986 |
Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Pindolol; Random Allocation | 1989 |
Effects of atenolol and pindolol on the hypokalaemic and cardiovascular responses to adrenaline infusion.
Topics: Adult; Atenolol; Blood Pressure; Electrolytes; Epinephrine; Female; Heart Rate; Hemodynamics; Humans; Hypokalemia; Male; Pindolol; Potassium | 1989 |
Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Pindolol; Random Allocation | 1989 |
Effect of pindolol versus atenolol on lipid profile in hypertensive patients.
Topics: Adult; Atenolol; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Pindolol | 1989 |
Intracellular sodium and calcium during antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Body Fluids; Calcium; Erythrocytes; Humans; Hypertension; Intracellular Fluid; Metipranolol; Middle Aged; Pindolol; Sodium; Sulfonamides | 1985 |
Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bicycling; Blood Pressure; Female; Humans; Hypertension; Isometric Contraction; Male; Mathematics; Metoprolol; Middle Aged; Pindolol; Propranolol; Random Allocation; Reaction Time; Thinking | 1985 |
Beta-blockers and sleep: a controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Electroencephalography; Female; Humans; Lipid Metabolism; Memory; Metoprolol; Pindolol; Propranolol; Random Allocation; Sleep; Sleep, REM; Solubility | 1985 |
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cholesterol; Cholesterol, HDL; Female; Half-Life; Heart Rate; Humans; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, VLDL; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Sotalol; Triglycerides | 1985 |
The influence of intrinsic sympathomimetic activity and beta-1 receptor selectivity on the recovery of finger skin temperature after finger cooling in normotensive subjects.
Topics: Acebutolol; Administration, Oral; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Double-Blind Method; Drug Evaluation; Female; Fingers; Forearm; Heart Rate; Humans; Male; Pindolol; Propranolol; Random Allocation; Skin Temperature | 1986 |
Thermogenesis in human skeletal muscle as measured by direct microcalorimetry and muscle contractile performance during beta-adrenoceptor blockade.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Body Temperature Regulation; Calorimetry; Double-Blind Method; Heart Rate; Humans; Male; Muscle Contraction; Muscles; Pindolol; Propranolol | 1986 |
Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Atenolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pindolol; Plethysmography, Whole Body | 1986 |
Swedish trial in old patients with hypertension. A prospective multicentre study in Swedish primary health care.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiloride; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Pindolol; Prospective Studies; Random Allocation; Sweden | 1986 |
Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propranolol | 1986 |
Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Benzeneacetamides; Blood Glucose; Circadian Rhythm; Diabetic Neuropathies; Electrocardiography; Heart Rate; Humans; Male; Middle Aged; Pindolol; Propanolamines; Tremor | 1987 |
Beta-blockers and lipophilicity.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Pindolol; Random Allocation | 1987 |
Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Captopril; Female; Forearm; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Leg; Male; Middle Aged; Myocardial Contraction; Pindolol; Regional Blood Flow; Vascular Resistance | 1987 |
Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pindolol; Random Allocation | 1987 |
Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
Topics: Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Hypertension; Intermittent Claudication; Labetalol; Leg; Male; Middle Aged; Pindolol; Random Allocation | 1987 |
Beta-blocker effects on sexual function in normal males.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Libido; Male; Metoprolol; Penile Erection; Pindolol; Propranolol; Random Allocation; Testosterone | 1988 |
Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Electrocardiography; Exercise; Hemodynamics; Humans; Pindolol; Rest; Systole | 1988 |
Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Pindolol; Pressoreceptors; Propranolol; Reflex | 1988 |
Adrenaline-induced amplification of sympathetic activity during rest and stress: inhibition by non-selective and beta 1-selective beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Epinephrine; Humans; Male; Middle Aged; Norepinephrine; Physical Exertion; Pindolol; Stress, Physiological; Sympathetic Nervous System | 1988 |
[Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
Topics: Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pindolol; Random Allocation | 1988 |
Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
Topics: Adult; Atenolol; Blood Glucose; Body Weight; Cholesterol, LDL; Cholesterol, VLDL; Drug Administration Schedule; Female; Humans; Hypertension; Insulin; Lipids; Male; Pindolol; Time Factors; Triglycerides; Uric Acid | 1988 |
Studies of the agonist and antagonist activity of cicloprolol in man.
Topics: Adult; Albuterol; Atenolol; Blood Pressure; Double-Blind Method; Exercise; Forearm; Heart Rate; Humans; Male; Pindolol; Prenalterol; Propanolamines; Random Allocation; Regional Blood Flow; Sleep | 1988 |
Comparison of the effects of pindolol and atenolol on hemodynamic function in systemic hypertension.
Topics: Adult; Atenolol; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pindolol | 1988 |
Haemodynamic effects of atenolol, pindolol and propranolol during adrenaline infusion in man.
Topics: Adult; Atenolol; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Forearm; Heart Rate; Hemodynamics; Humans; Male; Pindolol; Propranolol; Regional Blood Flow; Stroke Volume; Vascular Resistance | 1986 |
Changes in blood pressure, heart rate and thyroid hormones after sudden withdrawal of pindolol and atenolol in hypertensive patients.
Topics: Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pindolol; Random Allocation; Triiodothyronine | 1986 |
The effect of beta-blockade on leg blood flow in hypertensive patients with intermittent claudication.
Topics: Adult; Aged; Atenolol; Blood Flow Velocity; Blood Pressure; Gait; Humans; Hypertension; Intermittent Claudication; Leg; Male; Middle Aged; Pindolol; Prospective Studies; Sympathomimetics; Time Factors; Vascular Resistance | 1986 |
Effect of beta-blockers on plasma lipids.
Topics: Adult; Atenolol; Blood Pressure; Cholesterol; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Metoprolol; Middle Aged; Pindolol | 1986 |
Atenolol versus pindolol: side-effects in hypertension.
Topics: Adolescent; Adult; Atenolol; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Muscle Cramp; Pindolol; Random Allocation; Raynaud Disease; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Time Factors | 1985 |
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol | 1980 |
Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Catecholamines; Fatty Acids, Nonesterified; Heart Rate; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Metoprolol; Physical Exertion; Pindolol; Work | 1982 |
Assessment of beta-adrenoceptor antagonists in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Female; Forced Expiratory Volume; Humans; Male; Physical Exertion; Pindolol; Propranolol; Time Factors; Tremor | 1982 |
Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Carbon Dioxide; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Male; Metoprolol; Pindolol; Propranolol; Random Allocation; Respiration | 1982 |
Effect of the short-term beta-adrenoceptor blockade on exercise metabolism in cold weather.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; Cold Temperature; Growth Hormone; Humans; Insulin; Lipids; Male; Metabolism; Middle Aged; Physical Exertion; Pindolol; Running | 1984 |
Adrenergic beta-receptorblockade: haemodynamic relevance of beta-1-selectivity and ISA during adrenaline infusion.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Drug Interactions; Epinephrine; Heart Rate; Hemodynamics; Humans; Male; Pindolol; Propranolol; Receptors, Adrenergic, beta; Sympathetic Nervous System; Vascular Resistance | 1983 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Electrocardiography; Half-Life; Heart Rate; Humans; Kinetics; Male; Nadolol; Physical Exertion; Pindolol; Propanolamines; Time Factors | 1984 |
Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Pindolol; Random Allocation | 1984 |
Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Male; Middle Aged; Pindolol; Pulse; Random Allocation | 1984 |
[Value of a blood pressure profile in evaluating 2 antihypertensive agents].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure Determination; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Random Allocation | 1984 |
Effect of adrenaline on myocardial oxygen consumption during selective and non-selective beta-adrenoceptor blockade comparison of atenolol and pindolol.
Topics: Adult; Atenolol; Coronary Circulation; Epinephrine; Fatty Acids, Nonesterified; Humans; Middle Aged; Myocardium; Oxygen Consumption; Pindolol | 1984 |
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Monitoring, Physiologic; Physical Exertion; Pindolol; Propanolamines; Propranolol; Random Allocation; Time Factors | 1982 |
Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
Topics: Administration, Oral; Adolescent; Adult; Atenolol; Blood Glucose; Blood Pressure Determination; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Pindolol; Propanolamines; Propranolol; Respiratory Function Tests | 1981 |
[Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
Topics: Adult; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines; Propranolol | 1982 |
Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Atenolol; Atrial Fibrillation; Bradycardia; Digoxin; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Pindolol; Single-Blind Method | 1994 |
Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
Topics: Adult; Animals; Atenolol; Blood Pressure; Diastole; Double-Blind Method; Female; Guinea Pigs; Heart Rate; Humans; Iodine Radioisotopes; Iodocyanopindolol; Male; Myocardium; Physical Exertion; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; Reference Values; Stereoisomerism; Systole | 1993 |
Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Female; Fetal Heart; Hemodynamics; Humans; Infusions, Intravenous; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Uterus | 1995 |
beta-blockade, atrial natriuretic peptide and exercise.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Epinephrine; Exercise Test; Humans; Male; Norepinephrine; Pindolol; Propranolol; Vasopressins | 1996 |
Evaluation of the effect on heart rate variability of some agents acting at the beta-adrenoceptor using nonlinear scatterplot and sequence methods.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Atenolol; Double-Blind Method; Evaluation Studies as Topic; Heart Rate; Humans; Male; Nonlinear Dynamics; Pindolol | 1998 |
Baroreflex sensitivity and the blood pressure response to beta-blockade.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Baroreflex; Blood Pressure; Exercise; Exercise Test; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol | 1999 |
Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Cardiovascular Diseases; Cross-Sectional Studies; Digoxin; Female; Humans; Male; Middle Aged; Nociceptors; Pindolol; Propranolol; Young Adult | 2010 |
129 other study(ies) available for pindolol and atenolol
| Article | Year |
|---|---|
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2.
Topics: Adrenergic beta-Antagonists; Animals; Female; Guinea Pigs; Heart Rate; Hydrogen Bonding; Imidazoles; In Vitro Techniques; Receptors, Adrenergic, beta; Solubility; Structure-Activity Relationship | 1986 |
(Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.
Topics: Adrenergic beta-Antagonists; Amines; Carbamates; Cell Membrane Permeability; Pharmaceutical Preparations; Prodrugs | 1988 |
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors.
Topics: Adrenergic beta-Antagonists; Amides; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Drug Design; Epithelial Cells; Formamides; Humans; Intestinal Absorption; Liposomes; Models, Molecular; Molecular Conformation; Monte Carlo Method; Permeability; Propanolamines; Structure-Activity Relationship | 1998 |
Molecular hashkeys: a novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules.
Topics: Drug Design; Intestinal Absorption; Models, Molecular; Pharmaceutical Preparations; Structure-Activity Relationship | 1999 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.
Topics: Biological Availability; Biological Transport; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Reproducibility of Results | 2000 |
Experimental and computational screening models for the prediction of intestinal drug absorption.
Topics: Biological Transport; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Computational Biology; Drug Design; Foscarnet; Humans; Hydrogen Bonding; Intestinal Absorption; Intestinal Mucosa; Lactulose; Mannitol; Models, Biological; Raffinose; Surface Properties; Tritium; Verapamil | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Cell Line; Cell Survival; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Models, Molecular; Molecular Structure; Pyridines; Reverse Transcriptase Inhibitors; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Druggability profile of stilbene-derived PPAR agonists: determination of physicochemical properties and PAMPA study.
Topics: | 2019 |
Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart Rate; Pindolol; Practolol; Propranolol; Rats; Sympathomimetics | 1976 |
Once-daily treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Hypertension; Metoprolol; Pindolol; Propranolol; Timolol | 1976 |
Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Fatty Acids, Nonesterified; Heart Rate; Humans; Insulin; Isoproterenol; Male; Metoprolol; Pindolol; Practolol; Propranolol; Renin | 1978 |
Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arteriosclerosis; Atenolol; Blood Pressure; Depression, Chemical; Heart Rate; Isoproterenol; Male; Oxprenolol; Pindolol; Propanolamines; Propranolol; Rabbits; Timolol | 1978 |
The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Blood Pressure; Brain; Cats; Female; Heart Rate; Injections, Intraventricular; Male; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol | 1975 |
Renin-suppressive potency of various beta-adrenergic blocking agents at supine rest and during upright exercise.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Male; Oxprenolol; Physical Exertion; Pindolol; Posture; Practolol; Propranolol; Renin; Timolol | 1975 |
[Beta-blockers: redistribution of coronary blood flow and experimental myocardial ischaemia].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Endocardium; Microspheres; Pericardium; Pindolol; Practolol; Propranolol; Radioactivity | 1978 |
[Place of beta-blockers in the treatment of essential arterial hypertension].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Depression, Chemical; Drug Administration Schedule; Humans; Hypertension; Pindolol; Time Factors | 1978 |
Effects of beta-adrenergic blocking agents on peripheral vascular resistance.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Male; Pindolol; Propanolamines; Propranolol; Rats; Vascular Resistance | 1978 |
Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Drug Tolerance; Ethanolamines; Intraocular Pressure; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rabbits; Sotalol; Timolol | 1979 |
Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Humans; Male; Pindolol; Practolol; Propanolamines; Propranolol | 1979 |
Multiple heteroreceptors on limbic thalamic axons: M2 acetylcholine, serotonin1B, beta 2-adrenoceptors, mu-opioid, and neurotensin.
Topics: Atenolol; Autoradiography; Axons; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Ethanolamines; Limbic System; Neurotensin; Oxotremorine; Pindolol; Pirenzepine; Receptors, Adrenergic, beta; Receptors, Muscarinic; Receptors, Neurotensin; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Opioid, mu; Receptors, Serotonin; Thalamus; Tritium | 1992 |
Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Epinephrine; Humans; Hypertension; Isometric Contraction; Male; Middle Aged; Norepinephrine; Pindolol; Rest; Single-Blind Method; Stress, Physiological; Stress, Psychological | 1992 |
Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.
Topics: Adult; Analysis of Variance; Atenolol; Cardiography, Impedance; Cardiovascular System; Hemodynamics; Humans; Male; Pindolol; Propranolol; Reference Values | 1992 |
[Effects of antihypertensive therapy with selective and non-selective beta blocking agents on dimensions and function of the left ventricle].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Pindolol; Timolol; Ventricular Function | 1991 |
The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Celiprolol; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Lipids; Lipoproteins; Male; Pindolol; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Triglycerides | 1990 |
Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Labetalol; Male; Pindolol; Propranolol; Rats; Sexual Behavior, Animal | 1990 |
Separation of the enantiomers of beta-receptor blocking agents and other cationic drugs using a CHIRAL-AGP column. Binding properties and characterization of immobilized alpha 1-acid glycoprotein.
Topics: Adrenergic beta-Antagonists; Adsorption; Alprenolol; Atenolol; Binding Sites; Butylamines; Chromatography; Metoprolol; Molecular Structure; Orosomucoid; Oxprenolol; Pindolol; Propranolol; Protein Conformation; Spectrometry, Fluorescence; Stereoisomerism | 1990 |
Differential regulation of human cardiac beta-adrenergic and muscarinic receptors by chronic beta-adrenoceptor antagonist treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bisoprolol; Electric Stimulation; Humans; In Vitro Techniques; Iodocyanopindolol; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; N-Methylscopolamine; Parasympatholytics; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Receptors, Muscarinic; Scopolamine Derivatives | 1990 |
Atenolol and pindolol interfere with urinary 5-hydroxyindole-3-acetic acid.
Topics: Aortic Valve Stenosis; Atenolol; Colorimetry; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pindolol | 1986 |
Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
Topics: Animals; Atenolol; Differential Threshold; Dogs; Drug Combinations; Isoproterenol; Lidocaine; Metoprolol; Myocardial Contraction; Pindolol; Propranolol; Time Factors; Ventricular Fibrillation | 1987 |
Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Anesthesia; Animals; Atenolol; Benzopyrans; Cats; Ethanolamines; Exercise Test; Guinea Pigs; Hemodynamics; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Nebivolol; Pindolol; Propranolol; Rabbits; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1988 |
Functional characterization of beta-adrenoceptor subtypes in rabbit right atria.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Atrial Function; Binding, Competitive; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Iodocyanopindolol; Isoproterenol; Myocardial Contraction; Norepinephrine; Pindolol; Propanolamines; Rabbits; Receptors, Adrenergic, beta; Stimulation, Chemical; Terbutaline | 1989 |
Beta-adrenergic receptors on canine coronary collateral vessels: characterization and function.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Autoradiography; Collateral Circulation; Coronary Vessels; Dogs; In Vitro Techniques; Isoproterenol; Pindolol; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta | 1989 |
The antihypertensive effect of atenolol and bopindolol in the elderly.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1989 |
Effect of atenolol and pindolol on the phorbol ester-induced coronary vasoconstriction in the isolated perfused heart of the rat.
Topics: Animals; Atenolol; Coronary Vessels; Heart; In Vitro Techniques; Male; Perfusion; Phorbol Esters; Pindolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Vasoconstriction | 1988 |
Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Drug Therapy, Combination; Drug Tolerance; Female; Heart; Humans; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Verapamil | 1985 |
Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Individuality; Metoprolol; Oxidation-Reduction; Pindolol; Polymorphism, Genetic | 1985 |
Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Output; Coronary Disease; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pindolol; Practolol; Propranolol | 1985 |
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Epoprostenol; Humans; Labetalol; Pindolol; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aerosols; Aged; Atenolol; Blood Pressure; Female; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Metaproterenol; Middle Aged; Pindolol; Propranolol | 1986 |
Selective beta-antagonists are equally and highly potent at 5-HT sites in the rat hippocampus.
Topics: 5-Methoxytryptamine; 5,7-Dihydroxytryptamine; Adrenergic beta-Antagonists; Animals; Atenolol; Binding, Competitive; Ethanolamines; Hippocampus; In Vitro Techniques; Male; Membranes; Pindolol; Propranolol; Rats; Receptors, Serotonin; Serotonin | 1987 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, LDL; Oxprenolol; Penbutolol; Pindolol; Sotalol | 1987 |
The effect of beta-adrenoceptor blockers on the absorption and excretion of chlorothiazide in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Chlorothiazide; Half-Life; Humans; Male; Pindolol; Propranolol | 1987 |
Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Apolipoproteins; Atenolol; Humans; Lipids; Lipoprotein Lipase; Lipoproteins; Liver; Male; Nadolol; Pindolol; Propranolol | 1987 |
Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Arachidonic Acid; Arachidonic Acids; Atenolol; Blood Platelets; Collagen; Epinephrine; Humans; Metoprolol; Phospholipids; Pindolol; Platelet Aggregation; Thromboxane B2; Timolol | 1987 |
Beta-adrenoceptors in human tracheal smooth muscle: characteristics of binding and relaxation.
Topics: Atenolol; Binding, Competitive; Humans; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Pindolol; Propranolol; Receptors, Adrenergic, beta; Sarcolemma; Stereoisomerism; Trachea | 1987 |
Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Topics: Acebutolol; Atenolol; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pindolol; Propranolol; Renin; Time Factors; Vasodilation | 1988 |
Beta blocker treatment for angina with associated bradycardia.
Topics: Angina Pectoris; Atenolol; Bradycardia; Electrocardiography; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Pindolol | 1986 |
Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Atenolol; Collagen; Drug Synergism; Epoprostenol; Humans; Labetalol; Pindolol; Platelet Aggregation; Propranolol; Solubility; Sympatholytics | 1985 |
Comparison of four different beta-adrenoceptor blocking drugs on lymphocyte isoprenaline-stimulated cyclic AMP production.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Cyclic AMP; Drug Interactions; Female; Humans; Isoproterenol; Lymphocytes; Male; Middle Aged; Pindolol; Timolol | 1981 |
The effects of pindolol and prazosin on hand blood flow in patients with cold extremities and on treatment with beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cold Temperature; Female; Hand; Humans; Hypertension; Male; Middle Aged; Pindolol; Prazosin; Propanolamines; Quinazolines; Regional Blood Flow | 1981 |
Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Central Nervous System; Central Nervous System Diseases; Female; Humans; Male; Middle Aged; Pindolol; Propanolamines; Propranolol | 1981 |
Does beta-blockade directly reduce myocardial oxygen consumption?
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Atropine; Blood Pressure; Dogs; Heart; Heart Rate; Myocardium; Nitroprusside; Oxygen Consumption; Pindolol; Propanolamines | 1981 |
A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cardiovascular System; Female; Heart Rate; Isoproterenol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Sotalol | 1981 |
Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; Blood Pressure; Epinephrine; Fatty Acids, Nonesterified; Growth Hormone; Heart; Heart Rate; Humans; Male; Oxygen Consumption; Pindolol | 1981 |
Pharmacological approaches to the characterization of beta-adrenoreceptor populations in tissues.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cats; Female; Fenoterol; Guinea Pigs; Male; Muscle Contraction; Myocardial Contraction; Pindolol; Propanolamines; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Reserpine; Species Specificity | 1981 |
Withdrawal of beta-blocking drugs.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Physical Exertion; Pindolol; Propranolol; Substance Withdrawal Syndrome; Sympathomimetics | 1982 |
Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Electrophysiology; Female; Heart; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Pindolol; Rest; Sympathomimetics | 1982 |
Can ISA compensate for bradycardia due to beta-adrenoceptor blockade?
Topics: Adrenergic beta-Antagonists; Atenolol; Heart Rate; Humans; Pindolol; Propranolol; Sympathomimetics | 1982 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; Birth Weight; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Resuscitation | 1982 |
Effects of cardioselective and non-selective beta-adrenoceptor blockade on glycogenolysis, lipolysis and growth hormone secretion.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; Epinephrine; Glycogen; Growth Hormone; Heart; Heart Rate; Humans; Lipolysis; Male; Pindolol | 1982 |
[Therapy of essential tremor with special reference to the use of beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bupranolol; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol; Sotalol; Tremor | 1982 |
Effects of different beta-receptor antagonists on handgrip in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Isometric Contraction; Male; Middle Aged; Pindolol | 1982 |
Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Atenolol; Chemical Phenomena; Chemistry, Physical; Guinea Pigs; In Vitro Techniques; Male; Pindolol; Platelet Aggregation; Procaine; Propranolol; Verapamil | 1983 |
Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Hemodynamics; Humans; Hypertension; Metoprolol; Pindolol; Propanolamines; Time Factors; Timolol | 1983 |
The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Female; Humans; Hypertension; Lipids; Male; Pindolol; Platelet Aggregation | 1984 |
Fetal heart rate during treatment of maternal hypertension with beta-adrenergic antagonists. A preliminary report.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Fetal Heart; Heart Rate; Humans; Hypertension; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third | 1984 |
The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Cimetidine; Drug Interactions; Histamine H2 Antagonists; Humans; Kinetics; Metoprolol; Penbutolol; Pindolol; Propranolol; Ranitidine | 1984 |
[Role of transmembrane ion currents in the mechanism of action of beta-adrenoblockers].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart; Ion Channels; Labetalol; Oxprenolol; Pindolol; Propranolol; Rana ridibunda | 1984 |
Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Topics: Acetamides; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Cats; Coronary Circulation; Dogs; Hemodynamics; Isoproterenol; Macaca mulatta; Membranes; Myocardium; Nadolol; Organ Specificity; Oxygen Consumption; Pindolol; Propanolamines; Propranolol; Stroke Volume; Vascular Resistance | 1984 |
Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Dithiothreitol; Liver; Male; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Timolol; Triiodothyronine | 1984 |
Beta-adrenergic blockers. Choosing among them.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
Class III action of beta-blocking agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Ventricles; Male; Nadolol; Oxprenolol; Pindolol; Propanolamines; Propranolol; Sotalol; Timolol | 1984 |
Subclasses of beta-adrenoceptors--a quantitative estimation of beta 1- and beta 2- adrenoceptors in guinea pig and human lung.
Topics: Aged; Animals; Atenolol; Betaxolol; Cell Membrane; Guinea Pigs; Humans; Iodocyanopindolol; Lung; Metoprolol; Middle Aged; Models, Biological; Pindolol; Practolol; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1981 |
The interaction of cimetidine with metoprolol, atenolol, propranolol, pindolol and penbutolol.
Topics: Atenolol; Biological Availability; Cimetidine; Drug Interactions; Guanidines; Humans; Metoprolol; Penbutolol; Pindolol; Propanolamines; Propranolol | 1983 |
Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
Topics: Adult; Aged; Atenolol; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Metoprolol; Middle Aged; Pindolol; Propanolamines; Propranolol | 1980 |
Withdrawal of antihypertensive drugs in mild hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pindolol; Time Factors | 1981 |
The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
Topics: Adolescent; Adult; Aged; Atenolol; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Plasma; Propanolamines; Propranolol | 1981 |
[Clinical value of selective beta 1 block in antihypertensive therapy].
Topics: Adult; Atenolol; Female; Humans; Hypertension; Male; Oxprenolol; Pindolol; Propanolamines | 1981 |
Toxicity of beta-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; In Vitro Techniques; Metoprolol; Pindolol; Propranolol; Rats; Rats, Wistar | 1994 |
Effects of propranolol, pindolol and atenolol after multiple administration in rats on the duration of hexobarbital sleeping time and on the activity of some drug-metabolizing enzyme systems.
Topics: Animals; Atenolol; Cytochromes; Hexobarbital; Liver; Male; Mixed Function Oxygenases; Pindolol; Propranolol; Rats; Rats, Wistar; Sleep | 1993 |
Determination of beta-adrenoceptor subtypes in human pulmonary artery and thoracic aorta by radioligand binding.
Topics: Albuterol; Aorta; Atenolol; Binding, Competitive; Humans; Pindolol; Pulmonary Artery; Radioligand Assay; Receptors, Adrenergic, beta | 1993 |
Relative toxicity of beta blockers in overdose.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child, Preschool; Databases, Factual; Drug Overdose; Female; Humans; Infant; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Prospective Studies; Seizures; Sotalol | 1996 |
Potent inhibition of spontaneous rhythmic contraction by a novel beta 2-adrenoceptor agonist, HSR-81, in pregnant rat uterus.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Benzyl Alcohols; Binding, Competitive; Colforsin; Diestrus; Female; Gestational Age; In Vitro Techniques; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Isotope Labeling; Kinetics; Pindolol; Pregnancy; Propanolamines; Protein Binding; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Ritodrine; Uterine Contraction | 1996 |
Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Brain; Copulation; Ejaculation; Injections, Intraventricular; Male; Metoprolol; Pindolol; Propranolol; Rats; Sexual Behavior, Animal | 1996 |
Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Hypertension; In Vitro Techniques; Membranes; Myocardium; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 1996 |
Heterogeneity of beta-adrenoceptors in guinea-pig brain: radioligand binding and cyclic nucleotide generation.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Binding, Competitive; Cerebellum; Cyclic AMP; Cyclic GMP; Female; Guinea Pigs; Inositol Phosphates; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Male; Pindolol; Population; Propanolamines; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Signal Transduction; Vasodilator Agents | 1997 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
[Antioxidant effect of drugs used in cardiovascular therapy].
Topics: Adrenergic beta-Antagonists; Antioxidants; Ascorbic Acid; Atenolol; Calcium Channel Blockers; Copper; Female; Fluorescence; Humans; Lipid Peroxidation; Male; Metoprolol; Nifedipine; Pindolol; Propranolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Atrial Function; Dose-Response Relationship, Drug; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Male; Myocardium; Pindolol; Propranolol; Receptors, Adrenergic, beta; Time Factors | 1998 |
The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Celiprolol; Heart Ventricles; Isoproterenol; Male; Myocardial Contraction; Pindolol; Propranolol; Rats; Rats, Wistar | 1998 |
Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.
Topics: Adrenergic beta-Antagonists; Atenolol; Depressive Disorder, Major; Disability Evaluation; Drug Therapy, Combination; Follow-Up Studies; Humans; Long-Term Care; Metoprolol; Pindolol; Propranolol; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Beta1- and beta3-adrenoceptors mediate relaxation in ovine trachealis smooth muscle.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Ethanolamines; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-3; Sheep; Trachea | 1999 |
The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Retrospective Studies; Sympathomimetics; Syncope, Vasovagal; Tilt-Table Test | 1999 |
Beta-adrenoceptor modulation and heart rate variability--the value of scatterplot measures of compactness.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Analysis of Variance; Atenolol; Double-Blind Method; Heart Rate; Humans; Male; Pindolol; Propranolol; Randomized Controlled Trials as Topic | 2000 |
Nebivolol and airway responsiveness in the rabbit.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Animals; Atenolol; Benzopyrans; Dose-Response Relationship, Drug; Drug Interactions; Ethanolamines; Female; Histamine; Lung Compliance; Male; Nebivolol; Pindolol; Propranolol; Rabbits | 2001 |
Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Comorbidity; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Proportional Hazards Models; Propranolol; Recurrence; Syncope, Vasovagal; Treatment Failure | 2003 |
Use of vancomycin chiral stationary phase for the enantiomeric resolution of basic and acidic compounds by nano-liquid chromatography.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Chromatography, Liquid; Metoprolol; Nanotechnology; Pharmaceutical Preparations; Pindolol; Stereoisomerism; Vancomycin | 2005 |
Preparation and evaluation of propranolol molecularly imprinted solid-phase microextraction fiber for trace analysis of beta-blockers in urine and plasma samples.
Topics: Adrenergic beta-Antagonists; Adsorption; Alprenolol; Atenolol; Chromatography, High Pressure Liquid; Humans; Molecular Imprinting; Pindolol; Polymers; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction | 2009 |
Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzopyrans; Bisoprolol; Ethanolamines; Heart Failure; Heart Rate; Male; Metoprolol; Nebivolol; Pindolol; Propranolol; Rats | 2009 |
Restoration of neutrophil immunocompetence after cardiopulmonary bypass by beta-adrenergic blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Butoxamine; Catecholamines; Coronary Artery Bypass; Cytokines; Epinephrine; Flow Cytometry; Free Radicals; Humans; Immunocompetence; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Naphthyridines; Neutrophils; Pindolol; Prazosin | 2010 |
1H and 13C NMR characteristics of β-blockers.
Topics: Acebutolol; Acids; Adrenergic beta-Antagonists; Alkalies; Alprenolol; Atenolol; Carbazoles; Carbon Isotopes; Carvedilol; Nuclear Magnetic Resonance, Biomolecular; Pindolol; Propanolamines; Propranolol; Protons; Timolol | 2011 |
Simultaneous enantiomeric determination of propranolol, metoprolol, pindolol, and atenolol in natural waters by HPLC on new polysaccharide-based stationary phase using a highly selective molecularly imprinted polymer extraction.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, High Pressure Liquid; Environmental Monitoring; Metoprolol; Molecular Imprinting; Molecular Structure; Pindolol; Polysaccharides; Propranolol; Rivers; Solid Phase Extraction; Stereoisomerism; Water | 2012 |
The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis.
Topics: Antihypertensive Agents; Aryldialkylphosphatase; Atenolol; Atherosclerosis; Humans; Lipoproteins, HDL; Midodrine; Nadolol; Pindolol | 2019 |
In-Syringe Electrokinetic Protein Removal from Biological Samples prior to Electrospray Ionization Mass Spectrometry.
Topics: Acetaminophen; Atenolol; Blood Proteins; Chlorpheniramine; Clomipramine; Humans; Kinetics; Naproxen; Pindolol; Spectrometry, Mass, Electrospray Ionization; Syringes | 2020 |